Glimepiride
Product Images NDC 70934-323

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 70934-323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (70934 323 30 Rev A 03 19)

Label (70934 323 30 Rev A 03 19)
Glimepiride Tablets, USP 4 mg in a bottle containing 30 tablets, labeled by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label includes instructions to store at 25°C (77°F) with allowable excursions, and notes it is a prescription-only medication. The package also provides dosage information reference and safety warnings about keeping out of reach of children.*
FDA Label Image

Structure (Glimepiride Structure)

Structure (Glimepiride Structure)
Chemical structure of Glimepiride, illustrating its molecular composition with detailed connections including a cyclic urea and sulfonylurea functional groups, as well as a cyclohexyl ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.